FrostPharma
We are a pharmaceutical company focused on specialty medicines that meet patient and healthcare needs.

Who is FrostPharma
We are a fast-growing pharmaceutical company with our heart in the Nordics. Since its inception in 2017, FrostPharma has made available a large number of value-adding medicines in a number of different disease areas. Working closely with the healthcare community, we identify, develop and deliver medicines that make a difference - for patients, for healthcare and for society at large.
FrostPharma's portfolio also includes Woodsafe, read more here (link).
Our values underpin our culture, our decision-making and our strategic choices. Our values are:
- Entrepreneurship
- Speed
- Pragmatism
Who is Abboxia
Abboxia is a Swedish pharmaceutical company that provides specialty medicines that are in demand by healthcare professionals in the Nordic countries. This is done through the development, registration and marketing of drugs needed by the healthcare sector.
In August 2024, FrostPharma and Abboxia merged under the name FrostPharma and became one of the specialty pharmaceutical companies with a broad range of hospital drugs in the Nordic region.
FrostPharma's commercial strength and ability to build strategic alliances, combined with Abboxia's portfolio development capabilities, together create opportunities to deliver significantly more key hospital drugs to Nordic healthcare providers in the treatment of patients with critical conditions.


FrostPharma - an overview
- Founded in Stockholm in 2017
- 60+ products launched and more products on the way
- We develop and commercialize specialty medicines where we have identified unmet needs together with healthcare
- Expertise in key areas: marketing and sales, procurement, pricing, regulatory, pharmacovigilance, finance, logistics and business development
- Majority shareholder since 2023 is the private equity firm Priveq - an enabler of FrostPharma's growth strategy.
Where are we heading
Vision - a leading Nordic pharmaceutical company
Our vision is to become a leading Nordic pharmaceutical company, by offering high-quality, value-added specialty medicines.
Mission - Our mission
To provide specialty medicines that create value for patients, healthcare professionals and society.

